For years, pharmaceutical marketers have tried to convince themselves that the FDA accepted a standard under which risk information could be presented separately from benefit information via a hyperlink in online communications (the so-called one click rule). And for just as long, the Food and Drug Administration kept taking enforcement actions making clear that it […]
ACA Impacts on Rx Marketing for Disabled Americans: Fee-for-Value and Patient Lifestyle Autonomy
Health care coverage was expanded automatically to 32 million Americans in March 2010 when President Barack Obama signed into law the Patient Portability and Affordable Care Act (ACA). President Obama stated, ?My job is to set forward a vision ? point people in the right direction.? Since the ACA eliminated pre-existing conditions, developmentally, intellectually and […]
Meaningful Use as Digital Health Incubator
We?ve all heard about ?Meaningful Use,? but where did it come from, what does it mean, and how might healthcare consumers ultimately benefit? Let?s find out! Back in 2008 the National Quality Forum (NQF) issued a report identifying opportunities for improving public health, efficiency, safety, privacy, and patient engagement, among other areas. The recommendations became […]
DTC in Perspective: Patient Engagement–The Hot Topic
We are hearing the term patient engagement a lot these days. It is the subject of many blogs, articles and conferences. But what is it? That depends on who is defining it. From a drug makers perspective patient engagement is getting prospective drug users to know about your disease category, drug and keeping them persistent […]
Why the Healthcare Ecosystem Matters
Value-based reimbursement models have emerged to encourage new efficiencies aimed at improving population health and lowering the cost of care. With the realignment of incentives, the companies and organizations that comprise the healthcare ecosystem: primarily hospitals, medical groups and payers with connections to medical device, pharma, mHealth and others, have been working more closely than […]
Reaching the BFFs of Healthcare Social Media
Now that the majority of brands have established a social media presence, they?ve shifted from developing social media strategies to asking how they can use them to maximize patient engagement. But in order to identify the value of their efforts, marketers must gain an understanding of who they?re reaching, the social channels consumers prefer and […]
mHealth and Telemedicine: A Matter of Right and Not a Privilege
Senator Edward M. Kennedy?s landmark speech at the 1978 Democratic National Convention in Memphis, Tennessee emphatically brought attention to our nation?s health care dilemma, establishing his stance on health care as a matter of right and not of privilege. The human right to health care means that ?services must be accessible, available, acceptable, and of […]
Five Things Pharma Can Learn From CPGs
Pharma insiders sometimes dismiss the marketing campaigns of consumer-packaged goods (CPG) as being too far removed from our work to be relevant. ?They have such big budgets! They don?t have our restrictions! What can we learn from them?? A lot, we think. Group Account Director David Barwig, who is new to Intouch Solutions? New York […]
DTC in Perspective: Remembering Amgen?s Marker Weigand
Our colleague Marker Weigand passed away last week. Marker was a DTC colleague at Amgen who was stricken with ALS. He will be remembered by all who knew him as a wonderful person and loving family man. I am always shocked when someone so young passes prematurely. I knew Marker as a Facebook friend and […]
DTC in Perspective: FDA Studying Spousal Influence in DTC Ads
The FDA is interested in researching how drug ads are perceived when viewed alone versus with a spouse. They feel that when viewed with a spouse, drug benefit and risk may be interpreted differently. I think the study could yield interesting information. Does viewing with another person cause different benefit/risk takeaways? The FDA has a […]




